day before yesterday, on October 14, 2014 Verhovna Rada of Ukraine has adopted a few new laws on prevention and counteraction to corruption. These include, inter alia, a new basic anti-corruption law – the Law of Ukraine “On prevention of corruption”.
The main innovations under the new Law are as follows:
According to the Final and Transitional provisions the Law of Ukraine “On prevention of corruption” will enter into force from the date next to the date of its publication. On the same date currently effective Law of Ukraine “On principles of preventing and counteracting corruption” and Law of Ukraine “On principles of ethical behavior” will become invalid.
Herewith, Cabinet of Ministers of Ukraine will be obliged within 6-month-period from the date of entrance into force of the mentioned Law to carry out actions in order to ensure adoption and bring the relevant legal acts in line with the requirements of this Law, and to establish the National commission on prevention of corruption. Prior to the bringing the legal and other acts in line with the Law of Ukraine “On prevention of corruption” provision of such acts will be deemed valid unless they contradict with the Law.
Without any doubts the new Law will affect the activities of any and all pharmaceutical companies in Ukraine. In particular, pharmaceutical companies must adapt their inner politics, regulations and business-processes to the new legal requirements and rules. As far as Legal Alliance has profound practical skills within the sphere of complianceinpharmbusiness, we are ready to assist you to carry out all the required actions.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.